M Ta1, J George. 1. Southern Health Pharmacy Department, Casey Hospital and Department of Pharmacy Practice, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia. mai.ngoc@southernhealth.org.au
Abstract
BACKGROUND: Information on the management of chronic obstructive pulmonary disease (COPD) in Australia, especially the extent of adherence to the COPD-X Plan, is sparse. AIM: To evaluate COPD patient adherence to treatment recommendations and healthcare provider adherence to the COPD-X Plan. METHODS: Cross-sectional study of patients admitted to a secondary care hospital with an acute exacerbation of COPD over a 6-month period. Data were collected from patient interviews and medical notes. RESULTS: Participants (n= 45) aged 72 ± 11.5 years (mean ± SD) had a mean FEV(1) % predicted 52.2 ± 18.7. At the time 11 (24.4%) patients continued to smoke; 25 (55.6%) had never participated in a pulmonary rehabilitation programme; and 23 (51.1%) self-reported poor adherence to some COPD medications. Inhaler technique was deemed suboptimal in 25 (55.6%) patients. Only 11 (24.4%) patients had received any instructions from their doctor regarding management of exacerbations. The use of medications not supported by the COPD-X guidelines were: long-term prednisolone (11, 24.4%) and prophylactic antibiotics (3, 6.7%). CONCLUSION: Management of COPD in Australia by both patients and providers remains suboptimal despite the publication and wide dissemination of the COPD-X Plan, suggesting the need to intensify both patient and provider education in COPD management.
BACKGROUND: Information on the management of chronic obstructive pulmonary disease (COPD) in Australia, especially the extent of adherence to the COPD-X Plan, is sparse. AIM: To evaluate COPDpatient adherence to treatment recommendations and healthcare provider adherence to the COPD-X Plan. METHODS: Cross-sectional study of patients admitted to a secondary care hospital with an acute exacerbation of COPD over a 6-month period. Data were collected from patient interviews and medical notes. RESULTS:Participants (n= 45) aged 72 ± 11.5 years (mean ± SD) had a mean FEV(1) % predicted 52.2 ± 18.7. At the time 11 (24.4%) patients continued to smoke; 25 (55.6%) had never participated in a pulmonary rehabilitation programme; and 23 (51.1%) self-reported poor adherence to some COPD medications. Inhaler technique was deemed suboptimal in 25 (55.6%) patients. Only 11 (24.4%) patients had received any instructions from their doctor regarding management of exacerbations. The use of medications not supported by the COPD-X guidelines were: long-term prednisolone (11, 24.4%) and prophylactic antibiotics (3, 6.7%). CONCLUSION: Management of COPD in Australia by both patients and providers remains suboptimal despite the publication and wide dissemination of the COPD-X Plan, suggesting the need to intensify both patient and provider education in COPD management.
Authors: Lisa Pagano; Zoe McKeough; Sally Wootton; Stephen Crone; Deborah Pallavicini; Andrew S L Chan; Sriram Mahadev; Nicholas Zwar; Sarah Dennis Journal: Pilot Feasibility Stud Date: 2020-09-23
Authors: Jenifer Liang; Michael J Abramson; Nicholas Zwar; Grant Russell; Anne E Holland; Billie Bonevski; Ajay Mahal; Benjamin van Hecke; Kirsten Phillips; Paula Eustace; Eldho Paul; Kate Petrie; Sally Wilson; Johnson George Journal: BMJ Open Date: 2017-09-18 Impact factor: 2.692
Authors: Jeremy M Bunker; Helen K Reddel; Sarah M Dennis; Sandy Middleton; Cp Van Schayck; Alan J Crockett; Iqbal Hasan; Oshana Hermiz; Sanjyot Vagholkar; Guy B Marks; Nicholas A Zwar Journal: Implement Sci Date: 2012-09-07 Impact factor: 7.327
Authors: Gillian E Caughey; Adrian K Preiss; Agnes I Vitry; Andrew L Gilbert; Elizabeth E Roughead Journal: Diabetes Care Date: 2013-06-04 Impact factor: 19.112